Results 81 to 90 of about 97,174 (119)

ICOS-ImmunoPET Monitors T Cell Activation After Combination Immune Checkpoint Blockade in a Mouse Model of Melanoma Brain Metastasis. [PDF]

Adv Sci (Weinh)
Kuo RC, Verma R, Nagy SC, Kalita M, Aubert S, Ballesteros-Álvarez J, Almeida PM, Vogel H, Alam IS, Lim M, James ML.   +10 more
europepmc   +1 more source

Immune Checkpoint Blockade and Emerging Combination Platforms in Breast Cancer: A Narrative Review. [PDF]

Breast Cancer (Dove Med Press)
Abbaspour M, Esmaeil N, Akbari V, Ghoreishi M, Rafiepoor H.   +4 more
europepmc   +1 more source

Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate Cancer. [PDF]

Cancer Res
Siddiqui NA, Zhang L, DeLeon G, Naguib N, Zhang T, Quinn TP, Chen F, Aragon Sanabria V, Aditya A, Penarete D, Monette S, Socciarelli F, Pourbaghi M, Lee R, Lee C, Zanzonico PB, Scher HI, Overholtzer M, Wiesner U, Wolchok JD, Bradbury MS.   +20 more
europepmc   +1 more source

pAc/Emm55 increases anti-melanoma immunity via TLR2 signaling in dendritic cells and improves checkpoint blockade efficacy. [PDF]

Front Immunol
Le THN, Nguyen QT, Kim Y, Balkaran V, Bhathivi T, Pilon-Thomas S, Markowitz J.   +6 more
europepmc   +1 more source

Immune checkpoint blockade targets macrophage PD-1 to exacerbate metabolic dysfunction. [PDF]

Immunometabolism (Cobham)
Song Z, Frezza C.
europepmc   +1 more source

Immunogenic cell death as a cornerstone for combination therapies with immune checkpoint blockade. [PDF]

Mol Cancer
Niu Y, Zhu S, Fu K, Lai Y, Pan C, Yang Y, Li S, Wang X, To KKW, Wang F, Fu L.   +10 more
europepmc   +1 more source

Aging is associated with the outcomes of immune checkpoint blockade in renal cell carcinoma. [PDF]

J Immunother Cancer
Huang Z, Zhou J, Zheng Z, Zhao H, Zhao B, Zeng R.   +5 more
europepmc   +1 more source

Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer. [PDF]

Cancer Res
Gonzalez E, Kreger J, Liu Y, Wu X, Barbetta A, Baugh AG, Al-Zubeidy B, Jang JK, Shin SM, Zhang Z, Poissonnier A, Jacobo M, Stearns V, Connolly RM, Ho WJ, Emamaullee J, MacLean AL, Roussos Torres ET.   +17 more
europepmc   +1 more source

Pathologic Complete Response to Neoadjuvant Dual Checkpoint Blockade with Durvalumab Plus Tremelimumab in Advanced-Stage HCC: A Case Report. [PDF]

J Hepatocell Carcinoma
Bopp L, Beer M, Schmidt SA, Seufferlein T, Ettrich T, Rahbari NN, Birgin E.   +6 more
europepmc   +1 more source

Lipophilic Statins Deplete GPX4 to Promote Ferroptosis and Sensitize Cancer Cells to Immune Checkpoint Blockade. [PDF]

Mol Cancer Ther
Talty R, Brooks VT, McGeary MK, Milette S, Zheng S, Flem-Karlsen K, Daniels A, Deshmukh M, Park K, Caraccio W, Yan H, Echeandia-Francis C, McNamara M, Hong S, Kirwin DS, Olino K, Johnson CH, Bosenberg M, Micevic G, Roy SF.   +19 more
europepmc   +1 more source